DaVita Inc. ($DVA) Stock Forecast: Down 7.8% Today

What is DaVita Inc.?

DaVita HealthCare (DVA) operates kidney dialysis centers in the United States, offering services to patients with chronic kidney failure and end-stage renal disease.

Why is DaVita Inc. going down?

DVA stock is down 7.8% on Aug 6, 2025 18:36

• Despite strong second-quarter 2025 results, including surpassing earnings and revenue expectations and a rise in gross margin from core operations, DaVita HealthCare (DVA) faced significant bearish movement.
• There may be concerns about future growth, particularly related to uncertainties surrounding PD supply issues that could affect the company's performance.
• Investors might have anticipated even better outcomes or guidance for the future, which led to profit-taking and a decrease in the stock price despite positive financial results.
• The decline in DaVita's stock price could also be influenced by general market trends and challenges specific to the healthcare sector, resulting in a larger drop for DaVita compared to the overall market.

DVA Price Chart

DVA Technical Analysis

DVA News

DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands

DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.

https://www.zacks.com/stock/news/2674071/davita-stock-down-despite-q2-earnings-beat-gross-margin-expands

DaVita HealthCare ( DVA ) Q2 Earnings and Revenues Top Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of +9.26% and +1.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2669535/davita-healthcare-dva-q2-earnings-and-revenues-top-estimates

DaVita HealthCare ( DVA ) Registers a Bigger Fall Than the Market: Important Facts to Note

DaVita HealthCare (DVA) closed the most recent trading day at $140.37, moving 2.91% from the previous trading session.

https://www.zacks.com/stock/news/2645960/davita-healthcare-dva-registers-a-bigger-fall-than-the-market-important-facts-to-note

Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?

DVA rides early momentum from phosphate binders ahead of second-quarter 2025 earnings, but PD supply issues may cloud growth.

https://www.zacks.com/stock/news/2644950/can-phosphate-binders-drive-davita-stock-before-q2-earnings

Trending Today

Natural Gas ($GAS) Commodity Forecast: Up 5.1% Today

Toncoin ($TON) Crypto Forecast: Up 5.1% Today

MarketAxess Holdings Inc. ($MKTX) Stock Forecast: Down 9.6% Today

New York Times Company (The) ($NYT) Stock Forecast: Up 6.3% Today

Super Micro Computer Inc ($SMCI) Stock Forecast: Down 18.2% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 28.3% Today

Arista Networks Inc. ($ANET) Stock Forecast: Up 17.4% Today

Shopify Inc. Class A Subordinate ($SHOP) Stock Forecast: Up 22.3% Today

Advanced Micro Devices Inc. ($AMD) Stock Forecast: Down 7.0% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Down 10.6% Today

DaVita Inc. Price History

30.07.2024 - DVA Stock was down 2.7%

• The CFO and CEO of DaVita Inc. have recently sold a significant amount of company stock, totaling over $16 million, which could indicate a lack of confidence in the company's future performance.
• Insider selling can raise investor concerns about the company's prospects, leading to a negative sentiment in the market.
• The insider selling news may have contributed to a significant decline in DaVita's stock price today.
• Investors may view these insider sales as a warning sign and choose to sell their DaVita positions, causing the stock price to drop further.

30.09.2024 - DVA Stock was down 6.6%

• DaVita HealthCare (DVA) reported Q3 earnings that missed estimates by -6.16%, which could have contributed to the bearish movement.
• Despite an expected improvement in Revenue Per Treatment (RPT), the stock still experienced a negative change of -0.23%, possibly due to the earnings miss.
• Investors may be cautious about the future outlook of DVA, considering the earnings surprise and the slight decline in stock price.

30.09.2024 - DVA Stock was down 11.8%

• The bearish trend in DVA's stock can be linked to the company's Q3 earnings falling short of expectations.
• Despite strong Dialysis patient service revenues, the overall performance did not meet projections, leading to a negative market response.
• Investors' reaction to the -6.16% earnings surprise and 1.29% revenue miss likely contributed to the stock price drop.
• Market movements indicate investor caution regarding DVA's future performance and their interest in how the company addresses the missed estimates in the upcoming quarters.

12.08.2024 - DVA Stock was up 5.2%

• DaVita HealthCare (DVA) saw a bullish movement as the stock gained +0.29%.
• The company's focus on providing essential kidney care services in the US likely contributed to investor optimism.
• DaVita's intriguing valuation and its importance in societal health could have attracted investors looking for stable growth opportunities.
• The bullish trend in the stock reflects confidence in DaVita's business model and its position in the healthcare industry.

13.04.2025 - DVA Stock was down 5.8%

• Despite the bullish market sentiment, DaVita (DVA) faced significant bearish movement.
• The focus on Fox Corporation's earnings report could have detracted attention from DaVita's performance, prompting investors to realign their interests.
• Factors internal to DaVita or external circumstances not specified led to a negative market response.
• Despite favorable market conditions, investor wariness about DaVita's future prospects resulted in a stock sell-off.

14.00.2025 - DVA Stock was up 5.3%

• DVA displayed a robust bullish trend despite the market drop.
• This positive momentum may stem from solid financial performance or favorable developments in the healthcare sector.
• Investors seem to trust DaVita's capacity to manage market changes effectively and provide steady outcomes.
• The upward movement in DVA might reflect investor confidence in the company's future outlook and expansion opportunities in the healthcare field.

14.01.2025 - DVA Stock was down 13.1%

• DaVita's shares plunged over 10% in pre-market trading after Berkshire Hathaway trimmed its stake in the company, leading to investor concerns and selling pressure.
• The weak outlook for 2025 issued by DaVita, citing rising care costs and supply challenges, further contributed to the bearish sentiment surrounding the stock.
• Despite beating Q4 earnings and revenue estimates, the market reaction was overshadowed by Berkshire's sell-off and the cautious guidance provided by DaVita for the upcoming year.
• The combination of Berkshire's share reduction, disappointing future outlook, and ongoing industry challenges likely fueled the significant bearish movement in DaVita's stock price today.

22.06.2025 - DVA Stock was up 5.0%

• DVA showed a strong bullish movement, closing at $140.53, marking a 2.01% increase from the previous trading day despite the overall market downturn.
• Market sentiment towards DVA appears positive, potentially fueled by expectations of surpassing earnings estimates in the upcoming quarterly report, building on the company's track record.
• Investor optimism regarding DVA's future performance could be driving increased buying activity and pushing the stock price up.
• The uptick in DVA's performance may also be influenced by internal developments or positive sentiments in the market that have enhanced investor confidence in the stock.

06.07.2025 - DVA Stock was down 7.4%

• Despite DaVita HealthCare (DVA) beating earnings and revenue estimates in Q2, the stock saw a significant bearish movement.
• The larger fall in DVA compared to the overall market indicates specific factors affecting the company's stock price.
• The uncertainty surrounding PD supply issues may have contributed to the bearish trend in DVA's stock.
• Investors might be concerned about the potential impact of these supply issues on DaVita's future growth prospects, leading to the negative market movement.

06.07.2025 - DVA Stock was down 7.8%

• Despite strong second-quarter 2025 results, including surpassing earnings and revenue expectations and a rise in gross margin from core operations, DaVita HealthCare (DVA) faced significant bearish movement.
• There may be concerns about future growth, particularly related to uncertainties surrounding PD supply issues that could affect the company's performance.
• Investors might have anticipated even better outcomes or guidance for the future, which led to profit-taking and a decrease in the stock price despite positive financial results.
• The decline in DaVita's stock price could also be influenced by general market trends and challenges specific to the healthcare sector, resulting in a larger drop for DaVita compared to the overall market.

17.02.2025 - DVA Stock was up 5.2%

• Following a larger decline than the wider market in the prior trading session, DaVita HealthCare (DVA) staged a robust recovery today, suggesting a resurgence in investor confidence.
• The positive movement in the stock may be linked to factors such as strong financial performance, new business collaborations, or favorable developments within the healthcare field.
• Investors responded favorably to potential avenues for growth or strategic plans revealed by DaVita HealthCare, propelling the stock price upwards.
• The uptick in DVA's performance could also be ascribed to broader market sentiments, with investors showing interest in healthcare stocks amidst uncertainties in the overall market.

14.01.2025 - DVA Stock was down 10.5%

• Despite DaVita's strong performance in Q4 and improved margins, the stock faced a bearish trend, possibly hinting at elevated market expectations.
• The company's cautious future outlook, along with escalating care expenses, contributed to the unsatisfactory guidance that impacted the stock negatively.
• The decision of a major shareholder to offload some DaVita shares, as part of a predetermined arrangement, added to the selling pressure on the stock.
• Factors like reduced holdings by the major shareholder, weaker projections for 2025, and the market's response to the financial results and revenue forecasts likely instigated the notable decline in DaVita's stock value today.